Alector vs Lys Therapeutics
Alector
We are on a mission to make brain disorders history
141 employees · est. 2013 · South San Francisco, United...
Lys Therapeutics
First-in-class biotherapies against neurological diseases. Targeting neuroinflammation to tackle neurodegeneration
13 employees · est. 2021 · Lyon, France
Alector is the older company (2013 vs 2021); Alector is the larger of the two.
Side-by-Side Comparison
| Metric | Alector | Lys Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2021 |
| Headquarters | ||
| Headquarters | South San Francisco, United States | Lyon, France |
| Employees | ||
| Employees | 141 larger | 13 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | IPO | Non Equity Assistance |
| Total Funding | ||
| Total Funding | $495.50M | $6.10M |
| Funding Rounds | ||
| Funding Rounds | 8 | 5 |
| Services | ||
| Services | Development of therapies for neurodegenerative diseases, Conducting clinical trials, Research in human genetics, neuroscience, and immunology | Development and commercialization of biotherapies for neurological diseases |
| Target Customers | ||
| Target Customers | Patients with neurodegenerative diseases, Healthcare providers, Research institutions | Patients suffering from neurological diseases, healthcare professionals, pharmaceutical companies, research institutions |
| Taxonomy | ||
| Taxonomy | Neurodegenerative DiseasesClinical DevelopmentAntibody DiscoveryProtein EngineeringBlood-Brain Barrier TechnologyAlzheimer's Disease +8 | Neurodegenerative DisordersBiotherapiesNeuroinflammationBlood-brain BarrierMonoclonal AntibodyDrug Development +8 |
| Website | ||
| Website | alector.com | lystherapeutics.com |
About Alector
Alector, founded in 2013 and headquartered in the United States, is a cutting-edge player in the Biotechnology sector, focused on transforming approaches to Health Care and Pharmaceuticals. With the bold mission "to make brain disorders history," Alector is anchored in a late-stage clinical phase wi...
About Lys Therapeutics
Lys Therapeutics is a pioneering biotechnology company founded in 2021 with headquarters in France. The company's slogan, "First-in-class biotherapies against neurological diseases," encapsulates its primary focus on targeting blood-brain barrier (BBB) dysfunctions and neuroinflammation to revolutio...
Also comparing in this category
Comparing more than these two?
Get Alector, Lys Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Alector compare?
A PDF of Alector and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Frequently Asked Questions
Compare Alector with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Alector on 16 Jun 2026, and Lys Therapeutics on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
